American Cancer Society guidelines for the early detection of cancer

被引:324
作者
Smith, RA [1 ]
Cokkinides, V
von Eschenbach, AC
Levin, B
Cohen, C
Runowicz, CD
Sener, S
Saslow, D
Eyre, HJ
机构
[1] Amer Canc Soc, Canc Control Dept, Atlanta, GA 30329 USA
[2] Amer Canc Soc, Dept Epidemiol & Res Surveillance, Atlanta, GA 30329 USA
[3] Univ Texas, MD Anderson Canc Ctr, Program Ctr Genitourinary Canc, Houston, TX 77030 USA
[4] Mt Sinai Med Ctr, Div Gynecol Oncol, New York, NY 10029 USA
[5] Albert Einstein Coll Med, Dept Obstet & Gynecol, Bronx, NY 10467 USA
[6] Evanston NW Healthcare, Dept Surg, Evanston, IL USA
关键词
D O I
10.3322/canjclin.52.1.8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Each year the American Cancer Society publishes a summary of existing recommendations for early cancer detection, including updates, and/or emerging issues that are relevant to screening for cancer. In last year's article, the guidelines regarding screening for the early detection of prostate, colorectal, and endometrial cancers were updated, as was the narrative pertaining to testing for early lung cancer detection. Although none of the ACS's guidelines were updated in 2001, work is proceeding on an update of screening recommendations for breast and cervical cancer and an update of these guidelines will be announced in the January/February 2003 issue of CA. As in previous issues, we review recommendations for the "cancer-related check-up," in which clinical encounters provide case-finding and health counseling opportunities. Finally, we provide an update of the most recent data pertaining to participation rates in cancer screening by age, gender, and ethnicity from the Centers for Disease Control and Prevention's Behavioral Risk Factor Surveillance System (BRFSS) and National Health Interview Survey (NHIS).
引用
收藏
页码:8 / 22
页数:15
相关论文
共 66 条
[1]   Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria [J].
Bartsch, G ;
Horninger, W ;
Klocker, H ;
Reissigl, A ;
Oberaigner, W ;
Schönitzer, D ;
Severi, G ;
Robertson, C ;
Boyle, P .
UROLOGY, 2001, 58 (03) :417-424
[2]  
BASSETT L, 1994, CLIN PRACTICE GUIDEL, V13
[3]  
Baxter N, 2001, CAN MED ASSOC J, V164, P1837
[4]   Cost-effectiveness of 3 methods to enhance the sensitivity of Papanicolaou testing [J].
Brown, AD ;
Garber, AM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (04) :347-353
[5]   Recommendations for follow-up care of individuals with an inherited predisposition to cancer .2. BRCA1 and BRCA2 [J].
Burke, W ;
Daly, M ;
Garber, J ;
Botkin, J ;
Kahn, MJE ;
Lynch, P ;
McTierman, A ;
Offit, K ;
Perlman, J ;
Petersen, G ;
Thomson, E ;
Varricchio, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (12) :997-1003
[6]   Screening mammography re-evaluated [J].
Cates, C ;
Senn, S .
LANCET, 2000, 355 (9205) :750-750
[7]  
*CDC, 1996, CDC SURVEILLANCE SUM, V45, P4874
[8]   Assessment of nationwide cancer-screening programmes [J].
de Koning, HJ .
LANCET, 2000, 355 (9198) :80-81
[9]  
Dietrich A J, 1994, Arch Fam Med, V3, P176, DOI 10.1001/archfami.3.2.176
[10]  
DIETRICH JJ, 1992, BRIT MED J, V304, P91